1. Home
  2. IFBD vs SNOA Comparison

IFBD vs SNOA Comparison

Compare IFBD & SNOA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Infobird Co. Ltd

IFBD

Infobird Co. Ltd

HOLD

Current Price

$0.95

Market Cap

7.5M

Sector

Technology

ML Signal

HOLD

Logo Sonoma Pharmaceuticals Inc.

SNOA

Sonoma Pharmaceuticals Inc.

HOLD

Current Price

$1.34

Market Cap

6.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
IFBD
SNOA
Founded
2001
1999
Country
China
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
7.5M
6.4M
IPO Year
2020
2006

Fundamental Metrics

Financial Performance
Metric
IFBD
SNOA
Price
$0.95
$1.34
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
6.9K
200.3K
Earning Date
05-01-2023
06-16-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
32.26
EPS
N/A
N/A
Revenue
N/A
$19,529,000.00
Revenue This Year
N/A
$23.00
Revenue Next Year
N/A
$24.59
P/E Ratio
N/A
N/A
Revenue Growth
N/A
36.68
52 Week Low
$0.66
$0.85
52 Week High
$2.18
$4.80

Technical Indicators

Market Signals
Indicator
IFBD
SNOA
Relative Strength Index (RSI) 39.40 54.73
Support Level $0.87 $1.03
Resistance Level $1.09 $1.45
Average True Range (ATR) 0.08 0.10
MACD -0.01 0.00
Stochastic Oscillator 39.52 62.86

Price Performance

Historical Comparison
IFBD
SNOA

About IFBD Infobird Co. Ltd

Infobird Co Ltd is a software-as-a-service (SaaS) provider of AI-powered customer engagement solutions in China. The Company provides standard and customized customer relationship management cloud-based services, including SaaS and business process outsourcing (BPO) services. It generates revenue from the development and sale of software licenses for customized software, as well as from business integration solution services and digital advertising and marketing campaign services. Digital advertising revenue is generated from developing and executing advertising plans based on customer needs, and the Company generally provides limited warranties for work performed under its business integration solution contracts. The Company generates maximum revenue from its operations in Mainland China.

About SNOA Sonoma Pharmaceuticals Inc.

Sonoma Pharmaceuticals Inc is a specialty pharmaceutical company operating in the United States. It is engaged in identifying, developing, and commercializing differentiated therapies for patients living with chronic skin conditions. The company focuses on the development and commercialization of therapeutic solutions in medical dermatology to treat skin conditions, such as acne, atopic dermatitis, and scarring. The key products of the company are Celacyn, Ceramax Skin Barrier Cream, Mondoxyne, Alevicyn, SebuDerm, Microcyn, and Microcyn which are available for various skin treatments such as scars, itchy skin, minor skin irritations, rashes, and others. The company derives revenue from the sale of products in the United States, Latin America, Europe, Asia, and other countries.

Share on Social Networks: